Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
Active


Teva Pharms Inc's Family Patents


Family Patents



Teva Pharms Inc Drug List

Given below is the complete list of Teva Pharms Inc's drugs and the patents protecting them.


1. Alvaiz

Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

The market for generic drugs in the United States is projected to hit USD 231.69 billion.

19 Nov, 2025

Trends and Projections for the Generic Pharmaceuticals Market Through 2034 - openPR.com

18 Nov, 2025

Super Generics Market Projected to Reach USD 98.3 Billion by 2034, Fueled by Patent Expirations - openPR.com

07 Nov, 2025

Latest Updates on Orange Book Legal Battles: The Impact of Patent Conflicts on Prescription Practices...

06 Nov, 2025

See More